Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
Open Access
- 27 October 2009
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 101 (10), 1683-1691
- https://doi.org/10.1038/sj.bjc.6605403
Abstract
Background: Methods: Results: Conclusion:This publication has 52 references indexed in Scilit:
- Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist AntibodyJNCI Journal of the National Cancer Institute, 2008
- Functional antibodies produced by oncolytic clostridiaBiochemical and Biophysical Research Communications, 2007
- Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancerProceedings of the National Academy of Sciences of the United States of America, 2007
- Targeting death-inducing receptors in cancer therapyOncogene, 2007
- Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expressionBritish Journal of Cancer, 2007
- Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivoBritish Journal of Cancer, 2006
- TNF‐related apoptosis‐inducing ligand as a therapeutic agent in autoimmunity and cancerImmunology & Cell Biology, 2006
- TNFerade Biologic, an Adenovector With a Radiation-Inducible Promoter, Carrying the Human Tumor Necrosis Factor Alpha Gene: A Phase I Study in Patients With Solid TumorsJournal of Clinical Oncology, 2004
- Safety and antitumor activity of recombinant soluble Apo2 ligandJCI Insight, 1999
- Reconstitution of an SOS Response Pathway: Derepression of Transcription in Response to DNA BreaksCell, 1998